This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Novimmune Sa, Biomerieux Sa, Biomerieux, Inc.. Active years: 1996-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Geneva, CH (1996 - 2004)
- Chambesy-Geneve, CH (2004)
- Chambésy, CH (2010)
- Chambesy, CH (2013 - 2020)
Company Filing History:
6 out of 65 
1 out of 82 
1 out of 645 
Years Active: 1996-2020
Title: **Bernard Francois Mach: A Pioneer in Antibody Innovation**
Introduction
Bernard Francois Mach, based in Geneva, Switzerland, is a remarkable inventor with a significant contribution to the field of immunology. With a portfolio of nine patents, his work primarily focuses on the development of fully human monoclonal antibodies, specifically targeting the CD3 antigen. His innovative approaches have opened new avenues in therapeutic applications.
Latest Patents
One of Bernard's latest patents is titled "Anti-CD3 antibodies and methods of use thereof." This invention revolves around antibodies that are directed to the antigen CD3, providing essential advancements in biomedical research. The patent outlines fully human monoclonal antibodies aimed at CD3, detailing nucleotide sequences encoding heavy and light chain immunoglobulin molecules. It includes sequences that span framework regions and complementarity determining regions (CDRs), which are crucial for the antibody's function. Additionally, the patent describes hybridomas and other cell lines that express these immunoglobulin molecules and monoclonal antibodies, further illustrating the breadth of his innovative work.
Career Highlights
Bernard has held significant positions in renowned companies throughout his career. Notably, he has contributed his expertise at Novimmune SA and bioMérieux, Inc. His work in these organizations has bolstered his reputation as a leading inventor in the field of antibody development.
Collaborations
Throughout his professional journey, Bernard has collaborated with notable coworkers such as Yann Dean and Marie Kosco-Vilbois. These collaborations have enriched his research and enhanced the development of therapeutic solutions in immunology.
Conclusion
In conclusion, Bernard Francois Mach's innovative spirit and dedication to advancing antibody technology have greatly impacted the field of biomedical research. His extensive patent portfolio and collaborations reflect a commitment to improving health outcomes through the development of targeted immunotherapies. As the landscape of immunology continues to evolve, inventors like Bernard play a crucial role in navigating the challenges and breakthroughs that lie ahead.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile